Massive study to uncover how air pollution triggers lung cancer in india

NCT ID NCT07553598

Not yet recruiting Knowledge-focused Sponsor: All India Institute of Medical Sciences Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will enroll over 3,200 adults in Delhi and surrounding areas to understand how air pollution, especially fine particles (PM2.5), combines with other factors like smoking and genetics to increase lung cancer risk. Researchers will also look for biomarkers and identify groups most vulnerable, such as children and the elderly. The goal is to create a risk prediction model to guide prevention and policy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could lead to better ways to predict who is at highest risk for lung cancer from air pollution and guide prevention strategies.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test any drug or intervention, and results may take years to influence policy or clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

All India Institute of Medical Sciences

New Delhi, National Capital Territory of Delhi, 110029, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.